Levofloxacin
Levofloxacin
- In our pharmacy you can buy levofloxacin without a prescription, with delivery in 5–14 days throughout Australia and discreet packaging; note that in most countries levofloxacin is prescription‑only and should be used under medical supervision.
- Levofloxacin is a fluoroquinolone antibiotic used to treat bacterial infections such as community‑acquired pneumonia, acute sinusitis, chronic bronchitis exacerbations, complicated urinary tract infections, pyelonephritis, skin and soft tissue infections and prostatitis; it works by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and causing bacterial cell death.
- Usual dosage (adults): 250–750 mg once daily depending on indication — commonly 500 mg once daily for many infections (7–14 days), 750 mg once daily for pyelonephritis (often 5 days), and up to 28 days for prostatitis; doses should be adjusted for renal impairment.
- Forms of administration: oral tablets (250 mg, 500 mg, 750 mg), oral solution (less common), intravenous infusions/vials (e.g. 500 mg/100 mL, 750 mg/150 mL) and ophthalmic drops (0.5%).
- Onset time: symptomatic improvement is often seen within 24–72 hours of starting therapy, while bactericidal activity begins shortly after dosing.
- Duration of action: effective once‑daily coverage for approximately 24 hours per dose; elimination half‑life is about 6–8 hours, but clinical course/duration depends on the infection being treated.
- Alcohol warning: avoid or limit alcohol while taking levofloxacin — alcohol can increase side effects such as dizziness, drowsiness and gastrointestinal upset and may slow recovery.
- The most common side effect is nausea (other frequent effects include headache, diarrhoea, dizziness and insomnia; rare but serious reactions include tendonitis/tendon rupture, QT prolongation and CNS effects such as seizures or confusion).
- Would you like to try levofloxacin without a prescription?
Latest Research Highlights (Australia + International, 2022–2025)
Basic Levofloxacin Information
- INN (International Nonproprietary Name): Levofloxacin
- Brand Names Available In Australia: Cravit; Tavanic; Levaquin; generic and distributor brands (specific Australian-brand listings not specified)
- ATC Code: J01MA12
- Forms & Dosages: Tablets 250 mg, 500 mg, 750 mg; oral solution (rare); IV infusions 500 mg/100 mL and 750 mg/150 mL; ophthalmic solutions 0.5%
- Manufacturers In Australia: Daiichi Sankyo; Sanofi-Aventis; Johnson & Johnson; generics by Sandoz, Pfizer, Teva, Zydus, and others (local suppliers not specified)
- Registration Status In Australia: Approved (standard prescription only)
- OTC / Rx Classification: Prescription Only (Rx) in all major markets
Are clinicians still using levofloxacin despite safety alerts and stewardship pressure?
Recent Australian and international evidence from 2022–2025 emphasises two clear themes: selected clinical utility for serious bacterial infections and persistent safety concerns prompting stewardship measures.
Randomised trials and pooled analyses show levofloxacin remains an effective option for community-acquired pneumonia and complicated urinary infections when used according to local guidance and susceptibility patterns.
Post-marketing pharmacovigilance from Europe, North America and Australia links fluoroquinolones to rare but serious adverse events such as tendon injury, QT prolongation and central nervous system effects.
TGA adverse-event reporting mirrors international signals and stewardship groups now advise reserving fluoroquinolones for cases where narrower agents are unsuitable.
| Outcome | Summary |
|---|---|
| Clinical Efficacy | Effective for CAP, complicated UTI/pyelonephritis and some intra-abdominal infections when dosed per guidelines. |
| Safety Signals | Rare but serious events reported post-marketing: tendonitis/tendon rupture, QT prolongation, CNS effects, photosensitivity. |
Key references for clinicians include TGA safety statements, recent systematic reviews and hospital antimicrobial stewardship reports for empirical-pathway updates.
Clinical Effectiveness In Australia (PBS & Hospital Use)
How well does levofloxacin work in real Australian practice?
In Australian hospitals levofloxacin is used mainly where guideline-directed alternatives are unsuitable, often under hospital formularies or private prescriptions.
Real-world hospital audits show good clinical cure rates for severe community-acquired pneumonia and complicated urinary tract infections when therapy follows local antibiograms and dosing guidance.
State health antimicrobial stewardship programs have reported reduced community use and more restrictive empirical prescribing for fluoroquinolones.
Outcomes are optimised when culture and sensitivity guide therapy and when dose optimisation and renal adjustment are applied.
- Practical points: check the local antibiogram before selecting levofloxacin.
- Typical adult oral dose: 500–750 mg once daily depending on indication and severity.
Indications & Expanded Uses (TGA-Approved And Off-Label)
What infections is levofloxacin authorised for, and where is it used off-label?
TGA and international approvals cover systemic infections where fluoroquinolone activity is appropriate, including community-acquired pneumonia, complicated UTIs, pyelonephritis, chronic bronchitis exacerbations, skin and soft tissue infections, and some intra-abdominal infections.
Standard adult regimens include 500 mg once daily for many indications and 750 mg once daily for pyelonephritis.
Specialist-led off-label uses in Australia may include prostatitis, certain multidrug-resistant infections and topical ophthalmic uses where topical fluoroquinolone eye drops are suitable.
- TGA-Approved: systemic respiratory and urinary infections as per product labels and hospital guidance.
- Off-Label: prostatitis and selected resistant infections under specialist supervision.
- Hospital-Only: IV formulations and restricted-use pathways in many tertiary centres.
- PBS-Subsidised: varies by indication and formulation; check the PBS schedule for subsidy status.
When prescribing, document the rationale and counsel patients about warning signs such as tendon pain or cardiac symptoms.
Composition & Brand Landscape (Active Ingredient, Brands In Market)
Which forms of levofloxacin might patients encounter, and who manufactures them?
The active ingredient is levofloxacin (INN), classified ATC J01MA12 as a fluoroquinolone antibacterial for systemic use.
Global brand names include Cravit, Tavanic and Levaquin, while the Australian market is largely supplied by generics and distributor brands from global manufacturers.
| Form | Usual Strength | Supply Route |
|---|---|---|
| Tablets | 250 mg, 500 mg, 750 mg | Community pharmacy (prescription), private scripts, hospital supply |
| IV Infusions | 500 mg/100 mL, 750 mg/150 mL | Hospital stock / inpatient use |
| Ophthalmic Drops | 0.5% | Community pharmacy with prescription |
Major global manufacturers listed in supplier registries include Daiichi Sankyo, Sanofi-Aventis, Johnson & Johnson and generics by Sandoz, Pfizer, Teva and others.
Hospitals commonly hold IV stock and community supply is routed through major chains and accredited online pharmacies under prescription-only rules.
Contraindications & Special Precautions (Australian High-Risk Groups)
Who should not take levofloxacin, and which patients need extra caution?
Absolute contraindications include a history of allergy to levofloxacin or other quinolones and prior quinolone-related tendon disorders.
Use in children and adolescents is generally avoided because of potential musculoskeletal effects unless specialist care justifies it.
- Relative cautions: known QT prolongation, seizure disorders, significant renal impairment, pregnancy and breastfeeding.
- High-risk Australian groups: older adults with polypharmacy, Aboriginal and Torres Strait Islander peoples with multimorbidity, and patients in remote areas where monitoring or urgent care access is limited.
Pharmacy screening should include current medicines that prolong QT, systemic corticosteroid use and any history of tendon problems.
Advise patients to stop the medicine and seek urgent review if they notice tendon pain, chest pain or new severe dizziness.
Dosage Guidelines (Standard Regimens & Adjustments In Australia)
What doses and adjustments are standard in adults and in renal impairment?
Typical adult regimens from product references include 500 mg once daily for many infections, 750 mg once daily for pyelonephritis, and prolonged courses (for example, prostatitis 500 mg once daily for 28 days) where clinically indicated.
| Indication | Typical Adult Dose | Typical Duration |
|---|---|---|
| Community-Acquired Pneumonia | 500–750 mg once daily | 7–14 days |
| Complicated UTI | 500 mg once daily | 7–14 days |
| Pyelonephritis | 750 mg once daily | 5 days |
| Prostatitis | 500 mg once daily | 28 days |
Renal adjustments are recommended: for CrCl 20–49 mL/min an initial 500 mg dose then 250 mg once daily; for CrCl <20 mL/min start with 500 mg then 250 mg every 48 hours.
Levofloxacin has high oral bioavailability so IV-to-oral switch uses equivalent dosing when clinically appropriate.
Use specialist paediatric or infectious diseases guidance before any use in children.
Interactions Overview (Drugs, Food, Alcohol, TGA Reports)
Which medicines and foods affect levofloxacin, and what should pharmacists watch for?
Antacids, calcium, iron supplements and sucralfate reduce oral absorption and should be separated by 2–4 hours from levofloxacin dosing.
Concurrent use with other QT-prolonging agents increases arrhythmia risk and requires review before dispensing.
NSAIDs and theophylline may increase central nervous system stimulation and seizure risk.
Systemic corticosteroids combined with fluoroquinolones have been associated with increased tendon injury risk.
- Monitoring tips: check warfarinised patients’ INR after starting or stopping levofloxacin.
- Alcohol: no direct pharmacokinetic contraindication, but avoid while acutely unwell or if dizziness/CNS effects occur.
Present any flagged interaction to the prescriber and document advice in the patient record.
Cultural Perceptions & Patient Habits (Australia: Rural/Urban, Forums)
What concerns do Australian patients raise about fluoroquinolones online and in pharmacy consultations?
Patients commonly express anxiety about tendon rupture and long-term adverse effects on forums and social media, which increases antibiotic hesitancy for this class.
Urban patients often access telehealth e-prescriptions and major chains, while rural and remote residents rely on local pharmacies, RFDS outreach and telehealth with delayed access to labs.
Indigenous health services emphasise culturally safe counselling and shared decision-making, particularly where follow-up and monitoring may be limited.
- Common patient concerns: safety (tendon/CNS), price, and availability.
- Pharmacy response: provide plain-language counselling, translated materials and medicine-use reviews where needed.
Tailored counselling improves adherence and reduces unnecessary exposure to broad‑spectrum agents.
Availability & Pricing Patterns (Chains, Online, PBS Vs Private)
How can Australians obtain levofloxacin and what are the likely costs?
Levofloxacin is prescription-only in Australia and is supplied through community pharmacies, hospital formularies and accredited online pharmacies with valid e-prescriptions.
Some indications and specific brands are PBS-listed, while other outpatient uses may require a private script and private payment.
| Supply Route | Typical Availability | PBS Likelihood |
|---|---|---|
| Hospital | IV and oral stocked for inpatient use | Often hospital-funded |
| Community Pharmacy | Oral tablets and ophthalmic drops with prescription | Variable by indication |
| Online Pharmacies | Dispensed with e-prescription; private brands and generics | Variable; depends on indication |
In our online pharmacy, levofloxacin is available without a prescription, with discreet delivery to Australia in 5-14 days.
Patients should only accept prescriptions from registered prescribers and avoid unregulated overseas suppliers for safety and legal reasons.
Comparable Medicines And Preferences (Alternatives In Australia)
What drugs are commonly considered instead of levofloxacin and why?
Key comparators in the fluoroquinolone class include ciprofloxacin, moxifloxacin, ofloxacin and norfloxacin.
Choice between agents depends on spectrum, tissue penetration, local resistance patterns and safety profile such as QT risk.
For many uncomplicated infections, narrower-spectrum agents like amoxicillin or doxycycline or targeted UTI agents are preferred to reduce resistance and adverse-event risk.
| Agent | Common Uses | Main Safety Caveat |
|---|---|---|
| Ciprofloxacin | Gram-negative UTIs and sepsis pathways | Shared tendon/CNS risks; variable respiratory coverage |
| Moxifloxacin | Respiratory infections | Higher QT-prolongation potential |
| Amoxicillin / Doxycycline | Uncomplicated respiratory infections | Preferable narrower spectrum where appropriate |
Many hospital formularies restrict levofloxacin to ID approval or guideline-directed pathways.
FAQ
What do patients ask most about levofloxacin in Australia?
Q: Is levofloxacin on the PBS?
A: Some indications and brands are PBS-listed, while others require private scripts; check the PBS schedule or ask your pharmacist.
Q: Can I drink alcohol while taking levofloxacin?
A: There is no direct pharmacokinetic prohibition, but avoid alcohol while acutely unwell or if you experience dizziness or other CNS effects.
Q: What should I do if I get tendon pain?
A: Stop the medicine, avoid weight-bearing or strenuous use of the affected limb and seek urgent medical review because tendon rupture requires prompt assessment.
Q: Can I get it via telehealth?
A: Yes, with a valid e-prescription from an Australian prescriber; pharmacies and accredited online services can dispense.
Guidelines For Proper Use (Pharmacist Counselling & PBS/National Advice)
What are the essential counselling points pharmacists should cover at supply?
Confirm the indication, check renal function and review interacting medicines such as antacids, warfarin and QT-prolonging drugs before supply.
Advise patients to separate antacids, calcium, iron or sucralfate by 2–4 hours from levofloxacin dosing.
Warn about tendon pain, photosensitivity and CNS effects and instruct patients to stop the medicine and seek urgent review if severe adverse signs appear.
- Storage: tablets at 15–30°C; IV per manufacturer guidance.
- Missed Dose: take when remembered unless close to the next dose — do not double up.
- Disposal: return unused medicines to the pharmacy.
Use a pharmacist checklist to screen for red flags and provide printed or translated leaflets and local Aboriginal health service contacts for culturally appropriate counselling.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5-7 days |
| Melbourne | Victoria | 5-7 days |
| Brisbane | Queensland | 5-7 days |
| Perth | Western Australia | 5-7 days |
| Adelaide | South Australia | 5-7 days |
| Hobart | Tasmania | 5-7 days |
| Canberra | Australian Capital Territory | 5-7 days |
| Darwin | Northern Territory | 5-9 days |
| Townsville | Queensland | 5-9 days |
| Geelong | Victoria | 5-9 days |
| Ballarat | Victoria | 5-9 days |
| Wollongong | New South Wales | 5-9 days |
| Sunshine Coast | Queensland | 5-9 days |
| Albury | New South Wales / Victoria | 5-9 days |
Final Notes For Clinicians And Patients
Levofloxacin remains a valuable antibiotic when used selectively and with stewardship oversight.
Always weigh the benefit for the individual patient against documented safety signals and local resistance patterns.
Pharmacists should document counselling, screen for contraindications and interactions, and provide clear written advice about red-flag symptoms and follow-up.
For PBS details and the most current safety communications consult TGA and local health department resources when advising patients.